Targeted Approach to Metastatic Colorectal Cancer: What Comes Beyond Epidermal Growth Factor Receptor Antibodies and Bevacizumab?
Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834012462462
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 9, 2012
Authors
Publisher
SAGE Publications